लोड हो रहा है...
Neoadjuvant Therapy for Resectable Pancreatic Cancer: An Evolving Paradigm Shift
Non-metastatic pancreatic adenocarcinoma (PDAC) is associated with a high rate of recurrence and lethality. In addition, less than half of all patients are able to complete systemic therapy after curative-intent pancreatectomy. With its well-known potential benefits, this report highlights the curre...
में बचाया:
| में प्रकाशित: | Front Oncol |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Frontiers Media S.A.
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811513/ https://ncbi.nlm.nih.gov/pubmed/31681614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01085 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|